Literature DB >> 25941041

Lifestyle, attitudes and needs of uncured XDR-TB patients living in the communities of South Africa: a qualitative study.

Meera Senthilingam1, Elize Pietersen2, Ruth McNerney1, Julian Te Riele3, Pat Sedres2, Ruth Wilson2, Keertan Dheda2.   

Abstract

OBJECTIVE: Patient-level data are required to inform strategies interrupting transmission and default in patients with extensively drug-resistant TB (XDR-TB) to improve models of care and identify potential routes of transmission. We therefore explored the experiences, lifestyle, attitudes and needs of patients with uncured XDR-TB, who failed or interrupted therapy, living without treatment in the community.
METHODS: We conducted in-depth interviews with 12 community-based patients from South Africa. Family members were interviewed when patients were unavailable. Interviews were analysed using inductive thematic analysis.
RESULTS: The thematic experiences identified from the interviews were as follows: (i) living with but not being cured of XDR-TB, (ii) altered lifestyle in the community, (iii) experiences with community health care, (iv) local community members, and (v) wants and needs. Patients identified mistrust in health care, futility of treatment regimens, a need for a purpose in life and subsistence as major concerns. Restriction of living in the community for patients whose treatment had failed resulted in self-imposed isolation. Defaulters focused more on the never-ending drug regimen and bad experiences with health care contributing to non-adherence. Family members emphasised an under-recognised experience of unforeseen burden, obligation, worry and discomfort. Lack of knowledge and lack of concern about transmission was evident.
CONCLUSION: Current models of care are not adequately meeting the needs of patients with uncured XDR-TB and relatives. These data inform the need for community-based palliative care, vocational facilities to improve economic opportunities, home-based infection control and improved psychosocial support to increase patient adherence, reduce transmission, provide income and relieve the burden on family members.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Afrique du Sud; South Africa; Sudáfrica; cualitativo; extensively drug-resistant tuberculosis; fallo en el tratamiento; qualitatif; qualitative; resistance; resistencia; résistance; treatment failure; tuberculose; tuberculose ultra résistante; tuberculosis; tuberculosis extremadamente drogorresistente; échec du traitement

Year:  2015        PMID: 25941041     DOI: 10.1111/tmi.12532

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  5 in total

1.  Why test for tuberculosis? A qualitative study from South Africa.

Authors:  D Skinner; M Claassens
Journal:  Public Health Action       Date:  2016-12-21

2.  Public health and hospital-based nursing intersection: Case study of drug-resistant tuberculosis patients.

Authors:  Elize Pietersen; Kim Anderson; Yuri F van der Heijden
Journal:  Public Health Nurs       Date:  2022-01-06       Impact factor: 1.462

3.  Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.

Authors:  M R O'Donnell; A Daftary; M Frick; Y Hirsch-Moverman; K R Amico; M Senthilingam; A Wolf; J Z Metcalfe; P Isaakidis; J L Davis; J R Zelnick; J C M Brust; N Naidu; M Garretson; D R Bangsberg; N Padayatchi; G Friedland
Journal:  Int J Tuberc Lung Dis       Date:  2016-04       Impact factor: 2.373

4.  The role and response of primary healthcare services in the delivery of palliative care in epidemics and pandemics: A rapid review to inform practice and service delivery during the COVID-19 pandemic.

Authors:  Sarah Mitchell; Victoria Maynard; Victoria Lyons; Nicholas Jones; Clare Gardiner
Journal:  Palliat Med       Date:  2020-07-31       Impact factor: 4.762

5.  Knowledge, Attitudes, and Prevention Practices of Drug Resistant Tuberculosis in the Eastern Cape Province, South Africa.

Authors:  Thanduxolo Elford Fana; Edwin Ijeoma; Lizo Sotana
Journal:  Tuberc Res Treat       Date:  2019-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.